View Item 

Show simple item record

Estimated glomerular filtration rate with and without race for drug dosing: Cystatin C vs. serum creatinine
dc.contributor.authorYun, Hyun Gi
dc.contributor.authorSmith, Andrew J. F.
dc.contributor.authorDeBacker, Kenneth C.
dc.contributor.authorPai, Manjunath P.
dc.date.accessioned2023-03-03T21:10:27Z
dc.date.available2024-04-03 16:10:26en
dc.date.available2023-03-03T21:10:27Z
dc.date.issued2023-03
dc.identifier.citationYun, Hyun Gi; Smith, Andrew J. F.; DeBacker, Kenneth C.; Pai, Manjunath P. (2023). "Estimated glomerular filtration rate with and without race for drug dosing: Cystatin C vs. serum creatinine." British Journal of Clinical Pharmacology 89(3): 1207-1210.
dc.identifier.issn0306-5251
dc.identifier.issn1365-2125
dc.identifier.urihttps://hdl.handle.net/2027.42/175929
dc.publisherWiley Periodicals, Inc.
dc.subject.othercystatin C
dc.subject.othervancomycin dosing
dc.subject.otherglomerular filtration rate
dc.subject.othercreatinine
dc.subject.othercreatinine clearance
dc.titleEstimated glomerular filtration rate with and without race for drug dosing: Cystatin C vs. serum creatinine
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175929/1/bcp15592.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175929/2/bcp15592_am.pdf
dc.identifier.doi10.1111/bcp.15592
dc.identifier.sourceBritish Journal of Clinical Pharmacology
dc.identifier.citedreferenceDelgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022; 79 ( 2 ): 268 - 288.e1. doi: 10.1053/j.ajkd.2021.08.003
dc.identifier.citedreferenceInker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021; 385 ( 19 ): 1737 - 1749. doi: 10.1056/NEJMoa2102953
dc.identifier.citedreferenceUS Food and Drug Administration. Pharmacokinetics in patients with impaired renal function—study design, data analysis, and impact on dosing and labeling. September 3, 2020. Accessed April 12, 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pharmacokinetics-patients-impaired-renal-function-study-design-data-analysis-and-impact-dosing-and
dc.identifier.citedreferenceCrass RL, Pai MP. Estimating renal function in drug development: time to take the fork in the road. J Clin Pharmacol. 2019; 59 ( 2 ): 159 - 167. doi: 10.1002/jcph.1314
dc.identifier.citedreferenceBidell MR, Lodise TP. Suboptimal clinical response rates with newer antibiotics among patients with moderate renal impairment: review of the literature and potential pharmacokinetic and pharmacodynamic considerations for observed findings. Pharmacotherapy. 2018; 38 ( 12 ): 1205 - 1215. doi: 10.1002/phar.2184
dc.identifier.citedreferenceDowling TC, Matzke GR, Murphy JE, Burckart GJ. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy. 2010; 30 ( 8 ): 776 - 786. doi: 10.1592/phco.30.8.776
dc.identifier.citedreferenceDelanaye P, Cavalier E, Pottel H. Serum creatinine: Not so simple! Nephron. 2017; 136 ( 4 ): 302 - 308. doi: 10.1159/000469669
dc.identifier.citedreferenceOnopiuk A, Tokarzewicz A, Gorodkiewicz E. Cystatin C: a kidney function biomarker. Adv Clin Chem. 2015; 68: 57 - 69. doi: 10.1016/bs.acc.2014.11.007
dc.identifier.citedreferenceBarreto EF, Rule AD, Murad MH, et al. Prediction of the renal elimination of drugs with cystatin C vs creatinine: a systematic review. Mayo Clin Proc. 2019; 94 ( 3 ): 500 - 514. doi: 10.1016/j.mayocp.2018.08.002
dc.identifier.citedreferenceRybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006; 42 ( Suppl 1 ): S35 - S39. doi: 10.1086/491712
dc.identifier.citedreferenceCockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16 ( 1 ): 31 - 41. doi: 10.1159/000180580
dc.identifier.citedreferenceLevey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate [published correction appears in Ann Intern Med. 2008 Oct 7;149(7):519] [published correction appears in Ann Intern Med. 2021 Apr;174(4):584]. Ann Intern Med. 2006; 145 ( 4 ): 247 - 254. doi: 10.7326/0003-4819-145-4-200608150-00004
dc.identifier.citedreferenceLevey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011 Sep 20;155(6):408]. Ann Intern Med. 2009; 150 ( 9 ): 604 - 612. doi: 10.7326/0003-4819-150-9-200905050-00006
dc.identifier.citedreferenceInker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C [published correction appears in N Engl J Med. 2012 Aug 16;367(7):681] [published correction appears in N Engl J Med. 2012 Nov 22;367(21):2060]. N Engl J Med. 2012; 367 ( 1 ): 20 - 29. doi: 10.1056/NEJMoa1114248
dc.identifier.citedreferenceInker LA, Eckfeldt J, Levey AS, et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. 2011; 58 ( 4 ): 682 - 684. doi: 10.1053/j.ajkd.2011.05.019
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bcp15592.pdf
Size:
229.5KB
Format:
PDF
View/Open
Name:
bcp15592_am.pdf
Size:
346.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.